Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Jun-23 6:10 AM View:  | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 16-Jun-23 | Purchase | 15,000 | $0.54 | $8,050.00 | < 1% 1.8M to 1.81M | |
| 20-Jun-23 6:10 AM View: | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 15-Jun-23 | Private Purchase | 21 | $0.50 | $10.50 | < 1% 1.8M to 1.8M | |
| 15-Jun-23 7:15 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 14-Jun-23 | Private Purchase | 10,000 | $0.49 | $4,900.00 | < 1% 1.79M to 1.8M | |
| 28-Dec-22 9:45 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director 10% Owner | Vivos Therapeutics, Inc. (VVOS) | 23-Dec-22 | Private Purchase | 20,000 | $0.50 | $10,000.00 | 1% 1.77M to 1.79M | |
| 03-Jun-22 6:08 AM View: | Huntsman Ronald Kirk Chief Executive Officer Director 10% Owner | Vivos Therapeutics, Inc. (VVOS) | 01-Jun-22 | Private Purchase | 4,000 | $1.83 | $7,320.00 | < 1% 1.76M to 1.77M | |
| 03-Jun-22 6:08 AM View: | Huntsman Ronald Kirk Chief Executive Officer Director 10% Owner | Vivos Therapeutics, Inc. (VVOS) | 31-May-22 | Market Purchase | 8,000 | $2.03 | $16,240.00 | < 1% 1.76M to 1.76M | 1% |
| 22-Sep-21 10:00 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 21-Sep-21 | Market Purchase | 5,000 | $4.31 | $21,550.00 | < 1% 1.75M to 1.76M | 3% |
| 18-Aug-21 3:47 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 17-Aug-21 | Market Purchase | 5,000 | $3.00 | $15,000.00 | < 1% 1.75M to 1.75M | 12% |
| 25-May-21 9:45 PM View: | Amman Bradford K. Chief Financial Officer | Vivos Therapeutics, Inc. (VVOS) | 25-May-21 | Market Purchase | 1,000 | $5.29 | $5,290.00 | 100% 1.0K to 2.0K | |
| 25-May-21 9:45 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director | Vivos Therapeutics, Inc. (VVOS) | 25-May-21 | Market Purchase | 4,000 | $5.38 | $21,520.00 | < 1% 1.75M to 1.75M | 4% |
| 28-Dec-20 6:21 AM View: | Amman Bradford K. Chief Financial Officer | Vivos Therapeutics, Inc. (VVOS) | 24-Dec-20 | Market Purchase | 1,000 | $7.38 | $7,380.00 | 100% 0 to 1.0K | 0% |
| 23-Dec-20 6:53 PM View: | Huntsman Ronald Kirk Chief Executive Officer Director 10% Owner | Vivos Therapeutics, Inc. (VVOS) | 23-Dec-20 | Market Purchase | 1,000 | $7.27 | $7,266.90 | < 1% 1.75M to 1.75M | (< 1%) |
| 14-Dec-20 8:45 AM View: | Huntsman Ronald Kirk Chief Executive Officer Director 10% Owner | Vivos Therapeutics, Inc. (VVOS) | 11-Dec-20 | Purchase | 500 | $8.50 | $4,250.00 | < 1% 1.75M to 1.75M |
